What's in SUN PHARM INDUSTRIES's pipeline?

SUN PHARM INDUSTRIES has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with SUN PHARM INDUSTRIES's portfolio?

Top competitors by shared drug class: Advanz, Assistance Publique - Hôpitaux de Paris, Centers for Disease Control and Prevention, Centre de Recherche Médicale de Lambaréné, Epicentre.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sun-pharm-industries.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

SUN PHARM INDUSTRIES — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SUN PHARM INDUSTRIES pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Qualaquin	QUININE	marketed	Antimalarial	Sodium channel alpha subunits; brain (Types I, II, III)	Rare Disease	2005-01-01

Therapeutic area mix

Rare Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Advanz · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Centers for Disease Control and Prevention · 1 shared drug class
Centre de Recherche Médicale de Lambaréné · 1 shared drug class
Epicentre · 1 shared drug class
Frantz Viral Therapeutics, LLC · 1 shared drug class
GSK · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for SUN PHARM INDUSTRIES:

Cite this brief

Drug Landscape (2026). SUN PHARM INDUSTRIES — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sun-pharm-industries. Accessed 2026-06-10.